Results 31 to 40 of about 164,343 (265)

Chitosan nanoparticles containing limonene and limonene-rich essential oils: potential phytotherapy agents for the treatment of melanoma and breast cancers

open access: yesBMC Complementary Medicine and Therapies, 2021
Background Melanoma and breast cancers are two common cancers worldwide. Due to the side effects of chemotherapy drugs and the occurring resistance against them, the development of green drugs has been received more attention.
Hiva Alipanah   +4 more
doaj   +1 more source

Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance [PDF]

open access: yesYeungnam University Journal of Medicine, 2020
Systemic therapy for metastatic triple-negative breast cancer (TNBC) still remains challenging because there are no targeted agents or endocrine therapies currently available.
Dong Won Baek   +3 more
doaj   +1 more source

Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer

open access: yesTheranostics, 2021
Background: Neoadjuvant chemotherapy is relevant to the formation of thromboembolism and secondary neoplasms in triple-negative breast cancer (TNBC). Chemotherapy-induced breast cancer cell-derived microparticles (BCMPs) may have important thrombogenic ...
Cong Zhang   +17 more
semanticscholar   +1 more source

A new immunochemical strategy for triple-negative breast cancer therapy

open access: yesScientific Reports, 2021
Triple-negative breast cancer (TNBC) is a highly diverse group of malignant neoplasms which tend to have poor outcomes, and the development of new targets and strategies to treat these cancers is sorely needed.
Chih-Wei Lin   +5 more
semanticscholar   +1 more source

Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia
Objective Neoadjuvant chemotherapy (NACT) has become the standard of care for patients with triple-negative breast cancer (TNBC) with tumors > 1 cm or positive axillary nodes.
Maria Fernanda Imperio Pereira   +6 more
doaj   +1 more source

The neural crest transcription factor SOX 10 is preferentially expressed in triple negative breast carcinomas.

open access: yesInteramerican Journal of Health Sciences, 2021
Introduction: The expression of SOX 10 by immunohistochemistry has been documented in benign breast myoepithelial cells and in ductal carcinomas classified by the molecular subtype defined by immunohistochemistry.
A. Arra   +2 more
semanticscholar   +1 more source

Salivary gland-type mammary carcinoma arising in microglandular adenosis: A case report and clinicopathological review of the literature

open access: yesCancer Treatment and Research Communications, 2020
Introduction: Microglandular adenosis (MGA) is a rare benign proliferative lesion lacking a myoepithelial cell layer; 27% of all reported cases have progressed to invasive carcinoma.
Victoria Rico   +8 more
doaj   +1 more source

Association Between Family History of Malignant Neoplasms and Clinicopathological Features of Breast Cancer Patients

open access: yesZhongliu Fangzhi Yanjiu, 2020
Objective To investigate the association between family history of malignant neoplasms (MN-FH) and clinicopathological characteristics of patients with breast cancer.
CAO Xinhua   +4 more
doaj   +1 more source

CD151 Promotes Cancer Progression in Triple-Negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway

open access: yesBreast Cancer
Background Breast cancer has become one of the most prevalent malignant neoplasms among women, poses a significant threat to public health. As a member of the tetraspanin family of proteins, CD151 is implicated in tumor progression and has been shown to ...
Haishu Lv   +7 more
semanticscholar   +1 more source

Angiomyofibroblastoma of the uterine cervix in a patient with triple negative breast cancer: a case report

open access: yes, 2021
Angiomyofibroblastoma is an uncommon, benign mesenchymal tumor which generally occurs in the vulvovaginal region. Uterine cervix localisation is uncommon.
Dilara Özyiğit Büyüktalancı   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy